1Brake T, Paul F, Lamber. Estrogen contributes to the onset, persistence, andmalignant progression of cervical cancer in a humanpapillomavirus - transgenic mouse model[J]. PNAS, 2005,102(7) :2490 - 2495.
2Smith EM, Levy BT, Ritchie JM. Is use of HRT associated withincreased detection of human pap illomavirus and potential risk of HPV2related genital cancer [ J]. Eur J Cancer Prey, 2002,11 (3) : 295 - 305.
3Archer DF.Neoplasia of the female reproductive tract: effects of hormone therapy[ J]. Endocrine, 2004 , 24(3 ) : 259 - 263.
4Parazzini F, La Vecchia C, Negri E. Case2control study of oes2trogen rep lacement therapy and risk of cervical cancer[J]. BMJ, 1997,315(7100) : 85 - 88.
5Shagufta Yasmeen, Patrick S. Romano, Mary Pettinger, et al. Incidence of Cervical Cytological Abnormalities With Aging in the Women' s Health Initiative[ J]. Obstet Gynecol, 2006,108(3) :410 - 419.
6Schindler A E. Hormone replacement therapy(HRT)in women after genital cancer[ J]. Maturitas, 2002,41 (Suppl. 1 ) : S105 - S 111.
